← Back to Discover
Kedalion Capital Management LLP
Period ended Sep 30, 2026 · Latest filing Nov 6, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $4,287,323,019
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- SPDR SERIES TRUST · ST STR P500ETF · 78464A854 · shares: $4,036,507,200
- ISHARES TR · CORE S&P500 ETF · 464287200 · shares: $199,121,000
- ISHARES TR · IBOXX INV CP ETF · 464287242 · shares · CALL: $51,090,000
- WARNER BROS DISCOVERY INC · COM SER A · 934423104 · shares: $508,416
- ARBUTUS BIOPHARMA CORP · COM · 03879J100 · shares: $96,403
Reported holdings
5 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SPDR SERIES TRUST | ST STR P500ETF | 78464A854 | — | 44,970,000 shares | $4,036,507,200 |
| ISHARES TR | CORE S&P500 ETF | 464287200 | — | 260,000 shares | $199,121,000 |
| ISHARES TR | IBOXX INV CP ETF | 464287242 | CALL | 500,000 shares | $51,090,000 |
| WARNER BROS DISCOVERY INC | COM SER A | 934423104 | — | 16,427 shares | $508,416 |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | — | 20,168 shares | $96,403 |